Indicated for remission induction in: Acute Myeloid Leukemia (AML): In adults (often part of the "7+3" regimen). Acute Lymphocytic Leukemia (ALL): In both children and adults.

Dosage and administration

⚠️ STRICTLY Intravenous (IV) Administration Only! Extravasation (leakage under skin) causes severe tissue necrosis. Administration Rules: 💉 Administer into the tubing of a rapidly flowing IV infusion of saline. Dose is calculated based on Body Surface Area (mg/m²). Cumulative Dose Limit: The total lifetime dose should not exceed 550 mg/m² to prevent irreversible heart damage (cardiomyopathy).

Hypersensitivity to daunorubicin. Cardiac Disease: Heart failure, recent myocardial infarction, severe arrhythmias. Severe myelosuppression prior to treatment. Pregnancy (Teratogenic effects).

Common adverse reactions include: 🔴 Red Urine: Transient reddish discoloration of urine for 1-2 days (harmless). Cardiotoxicity: Arrhythmias or congestive heart failure (ECG monitoring required). Alopecia: Complete hair loss (reversible). Bone Marrow Suppression: Risk of infection and bleeding.

Daunotec — Daunorubicin 20 mg, 1 pcs, Cipla

100% original product

Active ingredient

Daunorubicin

Manufacturer

Cipla

Dosage 20 mg

Dosage form Vial

Vials per pack 1

Daunotec (Daunorubicin) 20 mg

Name: Daunotec
Brand: Cipla
SKU: PROD-12
Price: 1099 UAH
Availability: InStock

1099₴ ~~1318₴~~ -17%

Daunotec is a potent anthracycline antibiotic used in chemotherapy. Active ingredient: Daunorubicin (20 mg).

Manufacturer: Cipla (India). It works by interacting with DNA to inhibit macromolecular synthesis.

Key Characteristics:

Daunotec acts specifically during the S-phase of cell division. It is widely known for its bright red color and is a cornerstone in the treatment of acute leukemias.

✅ Usage: Typically used in combination regimens (e.g., with Cytarabine).

Indicated for remission induction in:

Acute Myeloid Leukemia (AML): In adults (often part of the "7+3" regimen).
Acute Lymphocytic Leukemia (ALL): In both children and adults.

⚠️ STRICTLY Intravenous (IV) Administration Only! Extravasation (leakage under skin) causes severe tissue necrosis.

Administration Rules:

💉 Administer into the tubing of a rapidly flowing IV infusion of saline.
Dose is calculated based on Body Surface Area (mg/m²).

Cumulative Dose Limit: The total lifetime dose should not exceed 550 mg/m² to prevent irreversible heart damage (cardiomyopathy).

Hypersensitivity to daunorubicin.
Cardiac Disease: Heart failure, recent myocardial infarction, severe arrhythmias.
Severe myelosuppression prior to treatment.
Pregnancy (Teratogenic effects).

Common adverse reactions include:

🔴 Red Urine: Transient reddish discoloration of urine for 1-2 days (harmless).
Cardiotoxicity: Arrhythmias or congestive heart failure (ECG monitoring required).
Alopecia: Complete hair loss (reversible).
Bone Marrow Suppression: Risk of infection and bleeding.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 23.03.2026

Active ingredient

Daunorubicin

Manufacturer

Cipla

Dosage 20 mg

Dosage form Vial

Vials per pack 1

100% original product

Delivery across Ukraine

Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Daunotec (Daunorubicin) 20 mg

What Customers Say

No reviews yet

Contact us

Request a call